Neoadjuvant therapy duration and outcome of patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC).

被引：0
|
作者：
Shahda, Safi
Perkins, Susan
Cramer, Harvey M.
House, Michael Garrett
Nakeeb, Attila
Zyromski, Nicholas J.
Ceppa, Eugene P.
Sehdev, Amikar
Akisik, Fatih
Lin, Jingmei
Schmidt, Christian
Ellsworth, Susannah G.
O'Neil, Nina
Link, Kristen
O'Neil, Bert
机构：
[1] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Indiana Univ Hlth, Simon Canc Ctr, Indianapolis, IN USA
[3] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[4] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[5] Indiana Univ, Indianapolis, IN 46204 USA
[6] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA
[7] Indiana Univ, Dept Radiat Oncol, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.436
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
436
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma
    Takaori, Ayaka
    Hashimoto, Daisuke
    Ikeura, Tsukasa
    Ito, Takashi
    Nakamaru, Koh
    Masuda, Masataka
    Nakayama, Shinji
    Yamaki, So
    Yamamoto, Tomohisa
    Fujimoto, Kosuke
    Matsuo, Yoshiyuki
    Akagawa, Shohei
    Ishida, Mitsuaki
    Yamaguchi, Kiyoshi
    Imoto, Seiya
    Hirota, Kiichi
    Uematsu, Satoshi
    Satoi, Sohei
    Sekimoto, Mitsugu
    Naganuma, Makoto
    [J]. PANCREATOLOGY, 2023, 23 (04) : 367 - 376
  • [2] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kaufmann, Benedikt
    Hartmann, Daniel
    D'Haese, Jan G.
    Stupakov, Pavel
    Radenkovic, Dejan
    Gloor, Beat
    Friess, Helmut
    [J]. DIGESTIVE SURGERY, 2019, 36 (06) : 455 - 461
  • [3] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1193 - 1198
  • [4] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    R. Álvarez
    I. Alés
    R. Díaz
    B. G. de Paredes
    M. Hidalgo
    [J]. Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
  • [5] Efficacy of Neoadjuvant Chemotherapy and Radiation in Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Eastburg, Benjamin
    Frisch, Austin
    Khan, Mariam
    Wright, Gerald P.
    Assifi, Mura
    Chandra, Sreenivasa
    Chung, Mathew
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S176 - S177
  • [6] Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Borhani, Amir A.
    Dewan, Rohit
    Furlan, Alessandro
    Seiser, Natalie
    Zureikat, Amer H.
    Singhi, Aatur D.
    Boone, Brian
    Bahary, Nathan
    Hogg, Melissa E.
    Lotze, Michael
    Zeh, Herbert J., III
    Tublin, Mitchell E.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 214 (02) : 362 - 369
  • [7] Long-term survival of patients receiving multimodality neoadjuvant therapy for resectable or borderline resectable pancreatic ductal adenocarcinoma
    McCormick, Kinsey
    Whiting, Samuel H.
    Gyurkey, Grace
    Koh, Wui-Jin
    Sinanan, Mika
    Coveler, Andrew L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma
    Suto, Hironobu
    Oshima, Minoru
    Ando, Yasuhisa
    Matsukawa, Hiroyuki
    Takahashi, Shigeo
    Shibata, Toru
    Kamada, Hideki
    Kobara, Hideki
    Masaki, Tsutomu
    Kumamoto, Kensuke
    Suzuki, Yasuyuki
    Okano, Keiichi
    [J]. HPB, 2023, 25 (01) : 136 - 145
  • [9] Letter to the editor: the nonnegligible effect of neoadjuvant therapy for patients with borderline resectable pancreatic ductal adenocarcinoma
    Wang, Li
    Zhang, Xin
    Lu, Yanrong
    Tian, Bole
    [J]. GLAND SURGERY, 2021, 10 (07) : 2340 - 2342
  • [10] Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
    Ei, Shigenori
    Takahashi, Shinichiro
    Ogasawara, Toshihito
    Mashiko, Taro
    Masuoka, Yoshihito
    Nakagohri, Toshio
    [J]. GUT AND LIVER, 2023, 17 (05) : 698 - 710
12345